140 related articles for article (PubMed ID: 2335259)
21. Uterine sarcomas: a clinicopathologic study.
Chiara S; Foglia G; Odicino F; Graziani A; Conte PF; Ragni N; Fulcheri E; Pescetto G
Oncology; 1988; 45(6):428-33. PubMed ID: 3186152
[TBL] [Abstract][Full Text] [Related]
22. Endometrial stromal sarcomas.
Yoonessi M; Hart WR
Cancer; 1977 Aug; 40(2):898-906. PubMed ID: 890670
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of patients with sarcoma of the uterus].
Bokhman IaV; Urmancheeva AF
Vopr Onkol; 1989; 35(10):1245-51. PubMed ID: 2596071
[TBL] [Abstract][Full Text] [Related]
24. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
25. Uterine/female genital sarcomas.
Hensley ML
Curr Treat Options Oncol; 2000 Jun; 1(2):161-8. PubMed ID: 12057054
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcoma-current management and experience from a regional cancer centre in North India.
Biswas A; Patel F; Kumar P; Srinivasan R; Bera A; Sharma SC; Rajwanshi A
Arch Gynecol Obstet; 2013 Oct; 288(4):873-82. PubMed ID: 23580012
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
28. Treatment of uterine sarcomas.
Echt G; Jepson J; Steel J; Langholz B; Luxton G; Hernandez W; Astrahan M; Petrovich Z
Cancer; 1990 Jul; 66(1):35-9. PubMed ID: 2354406
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
30. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
31. The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A; Cosio S; Romanini A; Genazzani AR
Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981.
Larson B; Silfverswärd C; Nilsson B; Pettersson F
Acta Oncol; 1990; 29(2):185-91. PubMed ID: 2334571
[TBL] [Abstract][Full Text] [Related]
33. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
[TBL] [Abstract][Full Text] [Related]
34. Endometrial stromal sarcoma of the uterus.
Meden H; Meyer-Rath D; Schauer A; Kuhn W
Anticancer Drugs; 1991 Feb; 2(1):35-7. PubMed ID: 1958850
[TBL] [Abstract][Full Text] [Related]
35. [Sarcomas of the uterus: morphological criteria and clinical course (author's transl)].
Eberl M; Pfleiderer A; Teufel G; Bachmann F
Pathol Res Pract; 1980 Oct; 169(2):165-72. PubMed ID: 7443573
[TBL] [Abstract][Full Text] [Related]
36. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract][Full Text] [Related]
38. Survival and risk factors associated with uterine sarcomas and carcinosarcomas in stage I and II.
Visnovsky J; Kudela E; Slavik P; Krkoska M; Buocik P; Szepe P; Danko J
Neuro Endocrinol Lett; 2015; 36(8):750-7. PubMed ID: 26921575
[TBL] [Abstract][Full Text] [Related]
39. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
40. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980.
De Fusco PA; Gaffey TA; Malkasian GD; Long HJ; Cha SS
Gynecol Oncol; 1989 Oct; 35(1):8-14. PubMed ID: 2792908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]